Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) — The “North America Biopreservation Market, By Country, Competition, Forecast & Opportunities, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.
North America Biopreservation Market was valued at USD 686.8 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.03% through 2029
The Biopreservation market has emerged as a critical player in the field of life sciences and healthcare, revolutionizing the storage and maintenance of biological materials. Defined as the process of preserving cells, tissues, or organs outside their natural environment to extend their viability, Biopreservation has become an indispensable tool across various industries, including pharmaceuticals, biotechnology, and healthcare.
The Biopreservation market is being propelled by several key factors, including the increasing demand for personalized medicine, growing investments in biobanking infrastructure, and the expanding field of regenerative medicine. With advancements in cell therapy, gene therapy, and organ transplantation, the need for effective preservation solutions has become more pronounced, driving the market forward.
One of the prominent trends shaping the biopreservation landscape is the rise of cryopreservation techniques. Cryopreservation involves storing biological samples at extremely low temperatures, typically below -130C, to arrest cellular activity and maintain sample integrity. This method has gained traction in preserving stem cells, embryos, and other valuable biological materials, contributing significantly to the market’s growth.
The pharmaceutical and biotechnology sectors are major contributors to the biopreservation market. As these industries continue to explore innovative therapies and drug development approaches, the demand for reliable biopreservation methods has surged. Biopreservation plays a pivotal role in maintaining the stability and efficacy of biological samples used in research and development, clinical trials, and manufacturing processes.
The applications of biopreservation are diverse, covering a spectrum of biological materials. In the healthcare sector, the preservation of organs for transplantation has witnessed significant advancements. Biopreservation ensures the viability of organs during transportation and prior to transplantation, addressing the critical challenge of organ shortages. In addition to organ preservation, biobanking has become a cornerstone of medical research. Biobanks store and manage a wide range of biological specimens, including blood, tissues, and DNA, for research purposes.
The North America rise in biobanking initiatives, driven by collaborative research endeavors and precision medicine initiatives, has contributed substantially to the expansion of the biopreservation market. The field of regenerative medicine, characterized by therapies that aim to repair, replace, or regenerate damaged tissues and organs, heavily relies on biopreservation. Stem cells, a key component of regenerative medicine, require precise preservation methods to maintain their therapeutic potential. As regenerative medicine continues to evolve, so does the demand for advanced biopreservation solutions.
While the biopreservation market thrives, it faces challenges related to the high costs associated with advanced preservation technologies and the need for standardization in storage and transport protocols. Addressing these challenges presents opportunities for market players to innovate and collaborate, fostering the development of more cost-effective and universally applicable solutions.
The growing awareness of the importance of preserving biological materials, coupled with the increasing prevalence of chronic diseases, sets the stage for continued expansion of the biopreservation market. Market participants are poised to capitalize on this momentum by investing in research and development, strategic collaborations, and technology advancements. In conclusion, the biopreservation market is a dynamic and evolving sector at the intersection of healthcare, biotechnology, and research. As the North America focus on personalized medicine, regenerative therapies, and advanced drug development intensifies, the role of biopreservation becomes increasingly pivotal.
The market’s journey over the next few years promises continued innovation, addressing challenges, and unlocking new possibilities for the preservation of biological assets. As the biopreservation market celebrates its one-year milestone, it stands as a testament to the indispensable role it plays in shaping the future of medicine and scientific exploration.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 125 |
| Forecast Period | 2023 – 2029 |
| Estimated Market Value (USD) in 2023 | $0.69 Billion |
| Forecasted Market Value (USD) by 2029 | $1.03 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | North America |
Report Scope:
Key Market Players
- Azenta US, Inc
- Biomatrica, Inc
- BioLife Solutions Inc
- MVE Biological Solutions
- LabVantage Solutions, Inc
- Taylor-Wharton International LLC
- Thermo Fisher Scientific, Inc
- Panasonic Corporation
- X-Therma Inc
- Princeton Cryotech Inc
North America Biopreservation Market, By Product:
North America Biopreservation Market, By Application:
- Regenerative Medicine
- Bio-banking
- Drug Discovery
North America Biopreservation Market, By Country:
- United States
- Canada
- Mexico
For more information about this report visit https://www.researchandmarkets.com/r/58x4pj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- North American Biopreservation Market
